Dr Philippe Calais

Guest Contributor
February 18, 2003

Dr Philippe Calais has been appointed president of Neurochem Inc. The announcement fills the second executive vacancy created by the departure of president and CEO Dr Louis Lamontagne last December. The CEO position was filled at that time by Dr Francesco Bellini, who is also the Montreal-based firm’s board chairman. Calais was previously GM of Servier Canada Inc and has held executive positions with Swiss-based Hoffman-La Roche and UK-based ICI Pharmaceuticals. He holds a PhD in pharmacy from the Univ Francois Rabelais. Bellini previously headed BioChem Pharma Inc until its sale to Shire Pharmaceuticals in 2001....

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.